Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.600 | disputed | 1.000 | 2 | 0 | 2015 | 2016 | ||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
WRN RecQ like helicase | 0.524 | 0.808 | 2.6E-34 |
|
disease | 1.000 | definitive | 0.952 | 7 | 0 | 1993 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily M member 4 | 0.633 | 0.577 | 5.7E-33 |
|
disease | 0.530 | disputed | 1.000 | 7 | 0 | 2012 | 2018 | ||||||||
|
myosin heavy chain 6 | 0.581 | 0.615 | 1.6E-32 |
|
disease | 0.660 | limited | 1.000 | 5 | 0 | 1984 | 2019 | ||||||||
|
myosin XVIIIB | 0.628 | 0.615 | 1.0E-31 |
|
disease | 0.700 | limited | 1.000 | 5 | 0 | 2003 | 2017 | ||||||||
|
coiled-coil domain containing 78 | 0.760 | 0.115 | 3.0E-31 |
|
disease | 0.500 | limited | 1.000 | 2 | 0 | 2012 | 2015 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.510 | limited | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
group | 0.300 | limited | 1.000 | 6 | 0 | 1996 | 2016 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
disease | 0.300 | limited | 1.000 | 6 | 0 | 1996 | 2016 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
disease | 0.390 | limited | 0.857 | 6 | 0 | 1996 | 2018 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
disease | 0.300 | limited | 1.000 | 6 | 0 | 1996 | 2016 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
disease | 0.300 | limited | 1.000 | 6 | 0 | 1996 | 2016 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
disease | 0.600 | moderate | 1.000 | 2 | 0 | 2000 | 2016 | ||||||||
|
ATPase copper transporting beta | 0.529 | 0.654 | 4.8E-30 |
|
disease | 1.000 | definitive | 0.980 | 9 | 0 | 1983 | 2020 | ||||||||
|
microcephalin 1 | 0.540 | 0.846 | 7.8E-30 |
|
disease | 0.310 | limited | 1.000 | 7 | 0 | 2005 | 2016 |